KMT2A and acute myeloid leukemia: Our data implicate FLNA downstream of CaSR as possible regulator of MLL-AF9+ AML and suggest possible CaSR-mediated effects on intracellular calcium levels, which may contribute to our observations in MLL-AF9+ AML.